Radiopharm Theranostics Limited (RDPTF) Net margin 2023–2025
Radiopharm Theranostics Limited (RDPTF) net profit margin by fiscal year — reported net income divided by reported revenue.
-1055.3%FY2025 · since FY2023: -11838.6% → -1055.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1055.3% | +14969.0 pp |
| FY2024 | -16024.3% | -4185.7 pp |
| FY2023 | -11838.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RDPTF financial trends
RDPTF RevenueRDPTF Net incomeRDPTF Gross profitRDPTF Gross marginRDPTF Operating incomeRDPTF Operating marginRDPTF Operating cash flowRDPTF Free cash flowRDPTF Capital expendituresRDPTF Return on equityRDPTF Stock buybacksRDPTF Dividends paidRDPTF Total assetsRDPTF Total liabilitiesRDPTF Shareholders’ equityRDPTF overview →